These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4435048)

  • 1. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 5. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.
    Rasmussen K; Aghajanian GK
    Brain Res; 1986 Oct; 385(2):395-400. PubMed ID: 3096493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in psychotomimetic phenylalkylamines.
    Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
    J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
    Glennon RA; Rosecrans JA; Young R
    Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763
    [No Abstract]   [Full Text] [Related]  

  • 10. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 11. An economical screen for phenethylamine-type hallucinogens: mouse ear scratching.
    Yim GK; Prah TE; Pfister WR; Nichols DE
    Commun Psychopharmacol; 1979; 3(3):173-8. PubMed ID: 574070
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
    Iriye TT; Kuna A; Simmonds FA
    Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT; Ho BT
    Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
    [No Abstract]   [Full Text] [Related]  

  • 15. The lack of correlation between hallucinogenesis and inhibition of axoplasmic transport.
    Paulson JC; McClure WO
    Mol Pharmacol; 1974 May; 10(3):419-24. PubMed ID: 4137280
    [No Abstract]   [Full Text] [Related]  

  • 16. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE; Pfister WR; Yim GK
    Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectrum analysis of EEG changes induced by psychotomimetic agents.
    Eidelberg E; Long M; Miller MK
    Int J Neuropharmacol; 1965 Sep; 4(5):255-64. PubMed ID: 5865229
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 20. The hallucinogens and the inhalants.
    Cohen S
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.